Drug Coated Balloon (DCB) Family: An Innovation in Itself

An advanced medical device in cardiovascular and vascular interventions which precisely combine angioplasty with targeted drug delivery, ensuring long-term arterial health.

Why Concept Medical’s DCB Family?

Concept Medical’s DCB is the world’s first Sirolimus-coated balloon family, delivering targeted medication, minimizing restenosis and promoting faster recovery without permanent implants. 

Backed by clinical success, DCBs provide sustained blood flow and versatile treatment for conditions ranging from coronary artery disease to erectile dysfunction.

We Treat with DCB

Our innovative sirolimus-coated balloon effectively treats cardiovascular and vascular conditions like In-Stent Restenosis (ISR), Small Vessel Coronary Artery Disease, Peripheral Arterial Disease (PAD), Arteriovenous Fistula (AVF) and Grafts (AVG) and Erectile Dysfunction (ED). 

Drug Coated Balloon

Your Health, Our Innovations

Discover Concept Medical’s diverse range of Sirolimus Coated Balloon Products designed to enhance treatment outcomes and improve lives.
One Scroll = One Slide
Tailored for treating small coronary vessels, this balloon combines innovative drug delivery with precision to enhance outcome. KNOW MORE
Developed for use in arteriovenous fistulas and grafts which helps maintain access site patency for dialysis patients and reduces blockages. KNOW MORE
Targeted for erectile dysfunction treatments, this balloon aids in restoring blood flow for enhanced patient quality of life. KNOW MORE
Specifically designed for percutaneous transluminal angioplasty, this balloon effectively addresses restenosis in peripheral arteries. KNOW MORE

The Game Changer Sirolimus Coated Balloon

Left Image 1
Left Image 2
Left Image 3
Left Image 4
Right Image 1
Right Image 2
Right Image 3
Right Image 4

The Game Changer Sirolimus Coated Balloon

Left Image 1
Left Image 2
Left Image 3
Left Image 4
Right Image 1
Right Image 2
Right Image 3
Right Image 4

Redefining Your Recovery with  NANOLUTE TECHNOLOGY

Nanolute technology revolutionizes Sirolimus delivery by enhancing its lipophilicity and bioavailability, ensuring targeted treatment by reducing inflammation and minimizes the risk of restenosis for optimal patient outcomes. 

Nanolute

Nanolute Technology

Technology

Nanolute

Technology